Using the TipRanks Stock Screener Tool, we identified three companies with high price-to-earnings (P/E) ratios, Strong Buy consensus ratings, and more than 50% upside potential over the next 12 months, making them attractive opportunities for growth-focused investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Let’s dive into the details.
Why High P/E Stocks?
An investment’s real value lies in its expected future growth. High P/E ratios might signal overpricing at first glance, but they often reflect strong optimism for rapid earnings expansion. The key is benchmarking current prices against projected growth paths. Investing in high P/E stocks is essentially wagering on companies with solid fundamentals, ongoing innovation, and expanding markets.
Workiva (WK)
- P/E Ratio: 103.1x
- Workiva’s average Price Target: $86.57 (55.90% upside)
Workiva is a cloud-based SaaS company that helps businesses and governments manage financial reporting, compliance, ESG reporting, and audit workflows. The company benefits from a high-retention SaaS model, where large enterprises keep expanding usage over time, supporting recurring revenue growth. Its P/E ratio can appear high or distorted since the company has historically had limited or inconsistent profitability, so the market instead focuses on recurring subscription revenue, strong retention, and long-term scalability of its compliance platform.
Nonetheless, analysts are bullish, driven by a mix of durable demand, long-term growth runway, and improving financial efficiency, even if near-term profitability remains limited. Analysts also like its positioning in regulatory reporting, ESG, and financial compliance, which are non-discretionary needs for Fortune 500 companies.
EHang Holdings (EH)
- P/E Ratio: 82.4x
- Average EHang Holdings’ Price Target: $15.53 (55.18% upside)
EHang is a Chinese advanced air mobility company that develops pilotless flying taxis (eVTOLs) and autonomous drones for passenger transport, logistics, and aerial services. The stock often trades at a high P/E mainly because earnings are still very small or inconsistent, while investors are pricing in strong future growth from the commercialization of its autonomous air taxi technology. In simple terms, the valuation is high because the market is betting on future demand, regulatory approvals, and scaling of eVTOL services, not current profits.
Looking ahead, analysts are bullish with a Strong Buy rating, backed by three Buys and one Hold assigned in the last three months.
Harrow Health (HROW)
- P/E Ratio: 68.0x
- Harrow Health’s Average Stock Price Target: $68.50 (69% upside)
Harrow Health is a U.S.-based specialty pharmaceutical company focused mainly on ophthalmology (eye-care drugs). Harrow’s high P/E isn’t because it’s extremely expensive in earnings terms today, but because it is still reinvesting heavily and not consistently profitable, so the market is pricing in future growth rather than current earnings. The company will report its Q1 2026 results on May 11.
Looking ahead, analysts are bullish with a Strong Buy rating, backed by eight Buys assigned in the last three months.